Clinical trial
Prospective, Double Blinded Randomized Multi-Center Controlled Trial Evaluating the 2 Different Doses of Lyophilized Amniotic Fluid Compared to a Saline Placebo Injection in the Treatment of Subjects With Osteoarthritic (OA) Knee Pain
NCT03074526 is registered in ClinicalTrials.gov with MiMedx Group, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Double Blinded Randomized Multi-Center Controlled Trial Evaluating the 2 Different Doses of Lyophilized Amniotic Fluid Compared to a Saline Placebo Injection in the Treatment of Subjects With Osteoarthritic (OA) Knee Pain
- Lead sponsor
- MiMedx Group, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 23, 2017
- Completion date
- April 25, 2018
- Enrollment
- 156 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.